Theme: Transforming the Future of Cytopathology & Histopathology

Cytopathology 2017

Cytopathology 2017

Honorable Panelists

Cytopathology 2017 Panelists, Philadelphia USA

Erozen is Professor Emeritus of Pathology, The Johns Hopkins University. He has been an active member of the American Society of Cytopathology. He has served the Society in multiple capacities including President. He has been a leader in the area of fine needle aspiration, one of the major new areas in Cytopathology in the last twenty-five years. His research interest in pulmonary pathology has involved the application of molecular probes to cytologic specimens. His papers have been published in significant journals of his specialty and he has been an Associate Editor for Acta Cytologica since 1992.

Yener S. Erozan
The Johns Hopkins University
USA
Rana Hoda is Chief of the Papanicolaou Cytology Laboratory and Director of the Cytopathology fellowship training program. Her primary clinical focus is cytopathology with special expertise in performing ultrasound-guided fine needle aspiration, urinary and gynecologic cytology and her research interests include ancillary tests in cytopathology and liquid based cytology among others. Hoda has published over 100 scientific papers, has published two text books including The Fundamentals of Pap Test Cytology. She is on the editorial board of several cytolopathology journals including Diagnostic Cytopathology, Journal of American Society of Cytopathology and Cytojournal.
Rana S. Hoda
Weill Cornell Medical College
USA
Yun Gong received MD degree in 1984 and then finished her post-graduate Pathology training in 1989 at Zhejiang Medical University in China. She then worked as a post-doctor and Research Associate in the Shanghai Institute of Cell Biology, Chinese Academy of Sciences; Catholic University of Nijmegen, The Netherlands; and The Scripps Research Institute, La Jolla, California. From 1998 to 2002, she received her residency training in Anatomic and Clinical Pathology at Northwestern University Medical School in Chicago, followed by one-year cytopathology fellowship training at MD Anderson Cancer Center. From 2003, she became a faculty member at the Dept of Pathology, MD Anderson Cancer Center, and currently is a Full Professor. She has numerous publications on these two fields (126 peer-review articles, 6 book chapters and one book, 120 abstracts). She is a member of 9 Editorial Boards of professional journals and is a member of the Scientific Program Committee, American Society of Cytopathology (ASC). She has been a Vice president and Chair of education/academic committee of CAPA.
Yun Gong
MD Anderson Cancer Center
USA

Li is an internationally recognized expert in the field of cytopathology and co-PI in Johns Hopkins Biomarker Discovery Center. She provides diagnostic service at Johns Hopkins, and conducts research in the field of novel biomarkers in lung and prostate cancers. Her research has been presented at many national/international meetings. Li also serves as editorial board members for several journals, committee member of the American Society of Cytopathology, and study sections of government agents and private organizations. She has more than 70 publications and book chapters. Li is also the editor of “Diagnostic Cytopathology Board Review and Self-Assessment”.

.

Shigeru Hirabayashi
Committee Member of American Society of Cytopathology
The Johns Hopkins University School of Medicine , USA
 

Keynote Speaker slot available..!!!





Conference Details

Cytopathology 2017 invites scholars, researchers, academicians, students and corporate entities across the globe to join at the 3rd International Conference on Cytopathology & Histopathology (Cytopathology-2017) to have a meaningful discussion with scholars during june 22-23, 2017 in Philadelphia, USA. The conference focuses on “Transforming Future of Cytopathology & Histopathology”.

 

 

Cytopathology 2017 anticipates participants all around the globe with thought provoking Keynote lectures, Oral, Young Researcher Forum and Poster presentations with Exhibition. The attending delegates include Editorial Board Members of related Journals.

After Successful completion of Cytopathology 2016, Conference Series LLC welcomes all to join the exclusive event 3rd International Conference on Cytopathology & Histopathology, Philadelphia, USA and showcase the recent research in the tremendous field of Cytopathology-Histopathology among the experts.

Students are warmly welcome to attend or to present their research work as Poster presenter and Young Researcher forum in this prestigious profile Cytopathologists & Histopathologists.

Who is attending?

  • Deans/Chairs, Vice Deans & Vice Presidents of Medical Institutions and Hospitals
  • Professors and students from academia who are in the field of research, Medical and clinical research.
  • Physicians, Business delegates, Directors / Managers & Business Intelligence Experts, Departmental Managers.

Benefits of Attending the Conference

  • The Career Guidance Workshops to the Graduates, Doctorates and Post-Doctoral Fellows, Certificate Accreditation from the Organizing Committee of presentation/ participation.
  • Accepted Abstracts will be published in the respective journals and will be labeled with a Digital Object Identification Number (DOI) provided by Cross Ref (Free abstract publishing).
  • Speaker and Abstract pages created in Google on your name would get worldwide acknowledgment to your profile and Research.
  • Best Poster and Young Researcher Award.

Supporting Journals:

Contact Person:

Robert Johnson

Program Manager | Cytopathology 2017

Phone:1-888-843-8169

Email: cytopathology@conferenceseries.net





Session Agenda

Cytopathology Congress one of the World's best platform on Pathology events will enable to put forth the holistic scientific approach to validating existing and development of Cytopathologic and Histopathologic techniques as to better understanding of diseases and diagnosis. Cytopathology conference is set to witness an exhilarating sessions in scientific program which will focus on latest innovations in Cancer Cytopathology, Clinical & Molecular Cytopathology, Stem Cell Therapy & Anatomical Pathology, Diagnostic & Comprehensive Cytopathology, General Cytopathology & Immunocytochemistry, Cytopathology & Disease diagnosis, Forensic Cytopathology, Genome Expression Profiling, Gene therapy, Bacterial & Microbial pathology Infection control, Veterinary Cytopathology.

Cytopathology Meeting will be the platform for business delegates, B2B meetings, poster presentations, Cytopathology workshops, Cytopathology symposia and much more. Past conference of Cytopathology meeting in 2015 & 2016 has grounded the best possible researchers in the field of Cytopathology & Histopathology from diverse scientific disciplines and opened the channels for research funding opportunities and collaborations, and so will be upcoming.

Track 1Cancer Cytopathology

Cytopathology usually used to aid in the diagnosis of cancer, but also helps in the diagnosis of certain infectious diseases and other inflammatory conditions. Cancer Cytopathology is generally used on samples of free cells or tissue fragments, in contrast to histopathology, which studies whole tissues. Cytopathologic tests are sometimes called smear tests because the samples may be smeared across a glass microscope slide for subsequent staining and microscopic examination. Gallbladder cancer is a relatively uncommon cancer and can be cure by fine needle aspiration material. However, cytology samples may be prepared in other ways, including cytocentrifugation. Different types of smear tests may also be used for cancer diagnosis. In this sense, it is termed a cytological smear. Epidemiology of Breast Cancer is the most commonly diagnosed cancer among women, with approximately 182,000 women diagnosed with breast cancer annually in the United States, accounting for approximately 26% of all incident cancers among women. Each year, 40,000 women die of breast cancer, making it the second-leading cause of cancer deaths among American women after lung cancer. The lifetime risk of dying of breast cancer is approximately 3.4%.

Relevant Cytopathology Conferences | Histopathology Conferences | Conference Series LLC

Personalized Medicine Conference, September 22-23, 2016 Phoenix, USA;  Internal Medicine Meeting, October 31-Nov 02, 2016 San Francisco, USA;  Personalized Medicine Congress, December 01-02, 2016 Valencia, Spain;  Pathologists Conference, December 05-06, 2016 Madrid, Spain;  Digital Pathology Congress, December 05-06, 2016 Madrid, Spain; Pediatric Pathology Conference, March 15-16, 2017 London, UK; Clinical Case Reports Conference, April 17-19, 2017 Dubai, UAE; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA

Track 2Diagnostic Cytopathology

Diagnostic Cytopathology Essentials is a succinct yet comprehensive guide to diagnosis in both non-gynecological and gynecological cytology. It provides quick answers to diagnostic problems in the cytological interpretation and recognition of a wide range of disease entities. Diagnosis of Cancer is nearly always diagnosed by an expert who has looked at cell or tissue samples under a microscope. In some cases, tests done on the cells’ proteins, DNA, and RNA can help tell doctors if there’s cancer. These test results are very important when choosing the best treatment options. Fine needle aspiration cytology is an inexpensive, a traumatic technique for the diagnosis of disease sites. It illustrates how it may be applied to the management of tumors throughout the body. The limitations of the method, the dangers of false positive reports, and the inevitability of false negative diagnoses are emphasized. In a clinical context the method has much to offer by saving patients from inappropriate operations and investigations and allowing surgeons to plan quickly and more rationally. It is an economically valuable technique and deserves greater recognition. Esophagus cancers are usually found because of signs or symptoms a person is having. If esophagus cancer is suspected, exams and tests will be needed to confirm the diagnosis. If cancer is found, further tests will be done to help determine the extent (stage) of the cancer.

Relevant Cytopathology Conferences | Histopathology Conferences | Conference Series LLC

Clinical Case Reports Conference, April 17-19, 2017 Dubai, UAE; Pathology Conference, April 24-26, Las Vegas, USA; Speech Language Pathology Conference, May 22-23, 2017 Las Vegas, USA; Cytopathology Conference, June 22-23, 2017 Philadelphia, USA; Molecular Pathology Conference, June 26-28, 2017 San Diego, USA; Euro Case Reports Conference July 27-29, 2017 Rome, Italy; Euro Pathology Conference, August 02-03, 2017 Milan, Italy; Microbial Pathogenesis Conference, August 24-25, 2017 Toronto, Canada; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA.

Track 3Histopathology

Histopathology is the science or study dealing with the cytological and histologic structure of the abnormal or diseased tissue. Although it refers to the microscopic examination of tissue in order to study the manifestations of the disease. The study of tissues is called Tissue histology and is important to the understanding of how the human body is able to function as a unit. In clinical medicine, histopathology refers to the examination of a biopsy or surgical specimen by a pathologist, after the specimen has been processed and histological sections have been placed onto glass slides. In contrast, cytopathology examines free cells or tissue fragments. Immunohistochemistry (IHC) refers to the process of detecting antigens (e.g. proteins) in cells of a tissue section by exploiting the principle of antibodies binding specifically to antigens in biological tissues.

Histology, There are four basic types of tissues: muscle tissue, nervous tissue, connective tissue, and epithelial tissue. All tissue types are subtypes of these four basic tissue types (for example, blood cells are classified as connective tissue, since they generally originate inside bone marrow).

Histopathology, the microscopic study of diseased tissue, is an important tool in anatomical pathology since accurate diagnosis of cancer and other diseases usually requires histopathological samples.

Relevant Cytopathology Conferences | Histopathology Conferences | Conference Series LLC

 Pathologists Conference, December 05-06, 2016 Madrid, Spain;  Digital Pathology Congress, December 05-06, 2016 Madrid, Spain; Pediatric Pathology Conference, March 15-16, 2017 London, UK; Clinical Case Reports Conference, April 17-19, 2017 Dubai, UAE; Pathology Conference, April 24-26, Las Vegas, USA; Speech Language Pathology Conference, May 22-23, 2017 Las Vegas, USA; Cytopathology Conference, June 22-23, 2017 Philadelphia, USA; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA.

Track 4Exfoliative Cytopathology

Exfoliative Cytopathology is the most significant and time-consuming area of practice for most anatomical pathologists. Surgical pathology involves gross and microscopic examination of surgical specimens, as well as biopsies submitted by surgeons and non-surgeons such as general internists, medical subspecialists, dermatologists, and interventional radiologists.

Relevant Conferences

Euro Medical Case Reports Conference, June 30-July 02, 2016 Valencia, Spain; Cytology & Histology Annual Meeting, August 11-12, 2016 Birmingham, UK; Molecular Pathology Congress, July 25-27, 2016 Melbourne, Australia; Pathology Conference,  May 09-11, 2016 Chicago, USA; Clinical Pathology Congress, Sept 26-28, 2016 Toronto, Canada; Applied Ergonomics Conference, 21–24 March 2016 Orlando, United States; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Advances in Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA.

Track 5Cervical Cytopathology

Cervical cytology became the standard screening test for cervical cancer and premalignant cervical lesions. Cytologic examinations may be performed on body fluids (examples are blood, urine, and cerebrospinal fluid) or on material that is aspirated (drawn out via suction into a syringe) of the body. Cytology also can involve examinations of preparations that are scraped or washed (irrigated with a sterile solution) from specific areas of the body. For example, a common example of diagnostic cytology is the evaluation of cervical smears (referred to as the Papanicolaou test or Pap smear).

There are several methods to screen for cervical cancer. The Pap test (also known as Pap smear or conventional cytology) and liquid-based cytology are widely used throughout the world and have been credited with greatly reducing the number of cases and mortality from cervical cancer in the developed world. Cytology-based tests have not been as effective in developing countries, leading to an investigation of cervical screening approaches more suited to low-resource settings such as visual inspection with acetic acid or HPV DNA testing.

Relevant Cytopathology Conferences | Histopathology Conferences | Conference Series LLC

Personalized Medicine Conference, September 22-23, 2016 Phoenix, USA;  Internal Medicine Meeting, October 31-Nov 02, 2016 San Francisco, USA;  Personalized Medicine Congress, December 01-02, 2016 Valencia, Spain;  Pathologists Conference, December 05-06, 2016 Madrid, Spain;  Digital Pathology Congress, December 05-06, 2016 Madrid, Spain; Pediatric Pathology Conference, March 15-16, 2017 London, UK; Clinical Case Reports Conference, April 17-19, 2017 Dubai, UAE; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA.

Track 6Fine-needle aspiration Cytology

Fine-needle aspiration biopsy (FNAB, FNA or NAB), or fine-needle aspiration cytology (FNAC), is a diagnostic procedure used to investigate superficial (just under the skin) lumps or masses. In this technique, a thin, hollow needle is inserted into the mass for sampling of cells that, after being stained, will be examined under a microscope. There could be cytology exam of aspirate (cell specimen evaluation, FNAC) or histological (biopsy - tissue specimen evaluation, FNAB). Gene expression profiling is the measurement of the activity (the expression) of thousands of genes at once, to create a global picture of cellular function. These profiles can, for example, distinguish between cells that are actively dividing, or show how the cells react to a particular treatment. Many experiments of this sort measure an entire genome simultaneously, that is, every gene present in a particular cell. Fine-needle aspiration biopsies are very safe, minor surgical procedures. Often, a major surgical (excisional or open) biopsy can be avoided by performing a needle aspiration biopsy instead. In 1981, the first fine-needle aspiration biopsy in the United States was done at Maimonides Medical Center, eliminating the need for surgery and hospitalization. Today, this procedure is widely used in the diagnosis of cancer and inflammatory conditions. Gene expression the appearance in a phenotype of a characteristic or effect attributed to a particular gene. The process by which possession of a gene leads to the appearance of the phenotype of the corresponding character.

Relevant Cytopathology Conferences | Histopathology Conferences | Conference Series LLC

Pathologists Conference, December 05-06, 2016 Madrid, Spain;  Digital Pathology Congress, December 05-06, 2016 Madrid, Spain; Pediatric Pathology Conference, March 15-16, 2017 London, UK; Clinical Case Reports Conference, April 17-19, 2017 Dubai, UAE; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA

Track 7Clinical & Molecular Cytopathology

Molecular Cytopathology is an emerging discipline within Cytopathology which is focused in the study and diagnosis of disease through the examination of molecules within organs, tissues or bodily fluids. Clinical pathology is a medical specialty that is concerned with the diagnosis of disease based on the laboratory analysis of bodily fluids, such as blood, urine, and tissue homogenates or extracts using the tools of chemistry, microbiology, hematology and molecular pathology. Cervical cancer is the third most common type of cancer among women worldwide. The infection and persistence of human papillomavirus (HPV) are the essential conditions for this type of disease. However, only HPV infection is not enough for cervical pathogenesis are necessary cofactors and activation of intracellular and extracellular mechanisms to start.

In the conventional Pap smear, the physician collecting the cells smears them on a microscope slide and applies a fixative. In general, the slide is sent to a laboratory for evaluation. The studies include Liquid-based monolayer cytology and Human papillomavirus testing. Diagnostic molecular pathology: Recent revolutionary progress in human genomics is reshaping our approach to therapy and diagnosis

Relevant Conferences:

Personalized Medicine Conference, September 22-23, 2016 Phoenix, USA;  Internal Medicine Meeting, October 31-Nov 02, 2016 San Francisco, USA;  Personalized Medicine Congress, December 01-02, 2016 Valencia, Spain;  Pathologists Conference, December 05-06, 2016 Madrid, Spain;  Digital Pathology Congress, December 05-06, 2016 Madrid, Spain; Pediatric Pathology Conference, March 15-16, 2017 London, UK; Clinical Case Reports Conference, April 17-19, 2017 Dubai, UAE; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA.

Track 8Cytopathology Case Reports

Cytopathology is the examination of cells from the body under the microscope to identify the signs and characteristics of the disease. Cytopathology is often loosely called "cytology," a word that simply means the study of cells.

A cytopathology report tells us whether the cells studied contain signs of disease. Cells examined for cytopathology can come from fluids extracted from body cavities - e.g. urine, sputum (spit), or fluids accumulating inside the chest or abdomen. Cells can also be extracted by inserting needles into lumps or diseased areas or tissues - called fine needle aspiration cytology (FNAC).

Laboratories may include recommendations as part of the Gynaecology Case reports. These may include a suggestion to the clinician for repeat cytology after a certain time interval or after treatment, or for tissue studies to further evaluate epithelial cell abnormalities.

Relevant Cytopathology Conferences | Histopathology Conferences | Conference Series LLC

Personalized Medicine Conference, September 22-23, 2016 Phoenix, USA;  Internal Medicine Meeting, October 31-Nov 02, 2016 San Francisco, USA;  Personalized Medicine Congress, December 01-02, 2016 Valencia, Spain;  Pathologists Conference, December 05-06, 2016 Madrid, Spain;  Digital Pathology Congress, December 05-06, 2016 Madrid, Spain; Pediatric Pathology Conference, March 15-16, 2017 London, UK; Clinical Case Reports Conference, April 17-19, 2017 Dubai, UAE; Pathology Conference, April 24-26, Las Vegas, USA; Speech Language Pathology Conference, May 22-23, 2017 Las Vegas, USA; Cytopathology Conference, June 22-23, 2017 Philadelphia, USA; Molecular Pathology Conference, June 26-28, 2017 San Diego, USA

Track 9General Cytopathology & Immunocytochemistry

Cytology, also known as cytotechnology or cytopathology, is a specialized field in medical lab technology in which technicians examine cells for signs of cancer. Fine Needle Aspiration (FNA) is a technique used to improve the clinical management of thyroid lesions, Thyroid Cytopathology. The introduction of a standardized and reproducible terminology system for diagnosis of a particular condition should reduce the need for unnecessary investigations and operations. Standardization of terminology is expected to improve patient safety and reduce risk to patients as any positive result will be identified and acted upon quickly. Immunocytochemistry (ICC) is a common laboratory technique that is used to anatomically visualize the localization of a specific protein or antigen in cells by use of a specific primary antibody that binds to it. The primary antibody allows visualization of the protein under a fluorescence microscope when it is bound by a secondary antibody that has a conjugated fluorophore.

The American Thyroid Association (ATA) is an international membership medical society with over 1,700 members from 43 countries around the world.  The ATA delivers its mission -of being devoted to thyroid biology and to the prevention and treatment of thyroid disease through excellence in research, clinical care, education, and public health. Likewise, Akrimax Pharmaceuticals, LLC, Bayer Healthcare/Onyx Pharmaceuticals, CBLPath, Endocrine Education, Inc. and much more are there in the tip of the growth of Cytopathology era.

Relevant Cytopathology Conferences | Histopathology Conferences | Conference Series LLC

 Pathologists Conference, December 05-06, 2016 Madrid, Spain;  Digital Pathology Congress, December 05-06, 2016 Madrid, Spain; Pediatric Pathology Conference, March 15-16, 2017 London, UK; Clinical Case Reports Conference, April 17-19, 2017 Dubai, UAE; Pathology Conference, April 24-26, Las Vegas, USA; Speech Language Pathology Conference, May 22-23, 2017 Las Vegas, USA; Cytopathology Conference, June 22-23, 2017 Philadelphia, USA; Molecular Pathology Conference, June 26-28, 2017 San Diego, USA; Euro Case Reports Conference July 27-29, 2017 Rome, Italy; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA.

Track 11Veterinary Cytopathology

Veterinary Cytopathology is concerned with the diagnosis of disease based on the gross examination, microscopic, and molecular examination of organs, tissues, and whole bodies (necropsy). Veterinary pathologists are doctors of veterinary medicine who specialize in the diagnosis of diseases through the examination of animal tissue and body fluids. Other than the diagnosis of disease in food-producing animals, companion animals, zoo animals and wildlife, veterinary pathologists also have an important role in drug discovery and safety as well as scientific research. Veterinary Clinical Sciences is concerned with the diagnosis of disease based on the laboratory analysis of bodily fluids such as blood, urine or cavitary effusions, or tissue aspirates using the tools of chemistry, microbiology, hematology and molecular pathology.

The Treatment of Veterinary Diseases of veterinary diseases is possible with the Veterinary clinical science with the help of the diagnosis pattern. Among the four major geographies namely North America, Europe, Asia-Pacific and Rest of the world, European region is known to be a leading veterinary vaccine market in terms of consumption, closely followed by the U.S. These two regions collectively account for more than 70% of the global veterinary vaccine market revenue.

Relevant Cytopathology Conferences | Histopathology Conferences | Conference Series LLC

Personalized Medicine Conference, September 22-23, 2016 Phoenix, USA;  Internal Medicine Meeting, October 31-Nov 02, 2016 San Francisco, USA;  Personalized Medicine Congress, December 01-02, 2016 Valencia, Spain;  Pathologists Conference, December 05-06, 2016 Madrid, Spain;  Digital Pathology Congress, December 05-06, 2016 Madrid, Spain; Pediatric Pathology Conference, March 15-16, 2017 London, UK; Clinical Case Reports Conference, April 17-19, 2017 Dubai, UAE; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA

Track 12: Gynecological and Breast Cytopathology

The role of the Cytopathology laboratory in the detection and presumptive identification of microorganisms. Sample procurement by exfoliation, abrasion, and aspiration techniques, as well as a variety of cytopreparatory and staining method. Gynecologic cancers are the uncontrolled growth and spread of abnormal cells originating in the female reproductive organs, including the cervix, ovaries, uterus, fallopian tubes, vagina, and vulva.

Making Strides In Breast Cancer: The most common type of breast cancer is a ductal carcinoma, which begins in the cells of the ducts. Breast cancer can also begin in the cells of the lobules and in other tissues in the breast. Invasive breast cancer is breast cancer that has spread from where it began in the ducts or lobules to surrounding tissue.

Relevant Conferences:

Personalized Medicine Conference, September 22-23, 2016 Phoenix, USA;  Internal Medicine Meeting, October 31-Nov 02, 2016 San Francisco, USA;  Personalized Medicine Congress, December 01-02, 2016 Valencia, Spain;  Pathologists Conference, December 05-06, 2016 Madrid, Spain;  Digital Pathology Congress, December 05-06, 2016 Madrid, Spain; Pediatric Pathology Conference, March 15-16, 2017 London, UK; Clinical Case Reports Conference, April 17-19, 2017 Dubai, UAE; Brain Injury Meetings 24–27 January, Santa Fe, USA; Conference on Cell Biology, March 18-20, 2016 Los Angeles, USA; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA.

Track 13Cytopathology & Disease diagnosis

 Cytology is a key component in diagnosis and screening of diseases such as cancer. Cytology disease diagnosis assesses single cells and clusters of cells from sources such as malignant effusions and peripheral blood. Effusions are fluids that leak from blood and lymph vessels and aggregate in tissues and cavities within the body. This is a common problem in cancer patients and can be a reservoir of malignant cells. However, the total number of cells in effusions is small in comparison to the volumes of fluids that are produced. Therefore, in order to collect these cells for evaluation, they must be concentrated. Liver disease diagnosis can often be difficult to diagnose because its symptoms can be vague and easily confused with other health problems. In some cases, a person may have no symptoms at all but the liver may already have suffered significant damage.

Gynecologic cytology, also gynecologic cytopathology, is a field of pathology concerned with the investigation of disorders of the female genital tract. The most common investigation in this field is the Pap test, which is used to screen for potentially precancerous lesions of the cervix. Cytology can also be used to investigate disorders of the ovaries, uterus, vagina and vulva.

Relevant Cytopathology Conferences | Histopathology Conferences | Conference Series LLC

Digital Pathology Congress, December 05-06, 2016 Madrid, Spain; Pediatric Pathology Conference, March 15-16, 2017 London, UK; Clinical Case Reports Conference, April 17-19, 2017 Dubai, UAE; Pathology Conference, April 24-26, Las Vegas, USA; Speech Language Pathology Conference, May 22-23, 2017 Las Vegas, USA; Cytopathology Conference, June 22-23, 2017 Philadelphia, USA; Molecular Pathology Conference, June 26-28, 2017 San Diego, USA; Euro Case Reports Conference July 27-29, 2017 Rome, Italy; Euro Pathology Conference, August 02-03, 2017 Milan, Italy; Cervical Cancer Conference, September 22-23, 2016 Vienna, Austria; Cancer Annual Symposium, April 30, 2016 Florida, USA.

Track 14: Urine Cytology

Cytology is the examination of cells from the body under a microscope. In a urine cytology exam, a doctor looks at cells collected from a urine specimen, to see how they look and function. The test commonly checks for infection, inflammatory disease of the urinary tract, cancer, or precancerous conditions. Urine cytology is better at finding larger and more aggressive cancers than small, slow growing cancers.

Relevant Conferences:

Personalized Medicine Conference, September 22-23, 2016 Phoenix, USA;  Internal Medicine Meeting, October 31-Nov 02, 2016 San Francisco, USA;  Personalized Medicine Congress, December 01-02, 2016 Valencia, Spain;  Pathologists Conference, December 05-06, 2016 Madrid, Spain;  Digital Pathology Congress, December 05-06, 2016 Madrid, Spain; Pediatric Pathology Conference, March 15-16, 2017 London, UK; Clinical Case Reports Conference, April 17-19, 2017 Dubai, UAE; Pathology Conference, April 24-26, Las Vegas, USA; Speech Language Pathology Conference, May 22-23, 2017 Las Vegas, USA; Cytopathology Conference, June 22-23, 2017 Philadelphia, USA; Molecular Pathology Conference, June 26-28, 2017 San Diego, USA.





Market Research Analysis

Cytopathology-2017 is a global event that brings together an unique and International mix of experts, researchers and decision makers both from academia and industry across the globe to exchange their knowledge, experience and research innovations to build a world Cytopathologists meet.

This meet enables a common platform for the participants to discuss their research in order to establish a scientific network between the academia and industry leading to Cytopathological technologies and innovations leads to explore new possibilities and improving the existed opportunities.

1. Key Competitive Conferences and their no. of attendees

There is huge number of events; workshop and symposium are going on Cytopathology & Histopathology as is an emerging field towards the diagnostic era.

2. Market research

Cytopathology therapies and diagnostics for Cervical Cancer the global cervical cancer market for drugs and diagnostics was $11.3 billion in 2012 and is expected to grow from $11.6 billion in 2013 to $15.6 billion by 2018, a compound annual growth rate (CAGR) of 6.1%.  Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.

  3. Societies and Associations on the topic

·         American Society of Cytopathology

·         Australian Society of Cytology

·         Papanicolaou Society of Cytopathology

·         The European Federation of Cytology Societies

 Many more…

4. Universities Located

University of Pennsylvania, USA

University of Pennsylvania, USA

Thomas Jefferson University, USA

Drexel University, USA

Temple University, USA

Pennsylvania State University – College of Medicine, USA

The Commonwealth Medical College, USA

Target Audience:

References:

https://en.wikipedia.org/wiki/Cytopathology

:  http://www.bccresearch.com/market-research/healthcare/cervical-cancer-therapies-diagnostics-hlc141a.html

http://www.bccresearch.com/pressroom/hlc/global-market-for-surgical-equipment-expected-to-increase-$8.2-billion-2018

http://www.bccresearch.com/market-research/healthcare/optical-coherence-tomography-global-markets-technologies-oct-report-hlc097b.html          

http://www.bccresearch.com/market-research/pharmaceuticals/diagnostics-therapeutics-lung-cancer-markets-report-phm174a.html





Past Conference Report

Cytopathology 2016

2nd International Conference on Cytopathology & Histopathology was organized during August 10-12, 2016 at Las Vegas, USA. With the support and contribution of the Organizing Committee Members, we successfully hosted the event at the conference venue.


Past Reports  Gallery  



Past Conference Report

Cytopathology-2015

International Conference on Cytopathology (Cytopathology-2015) was held during August 31-September 02, 2015 at Toronto Airport Marriott Hotel, Canada. The conference was marked with the attendance of Editorial Board Members of supported OMICS Group Journals, Scientists, young and brilliant researchers, business delegates and talented student communities representing more than 30 countries, who made this conference fruitful and productive.


Past Reports  Gallery  



Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date June 22-23, 2017
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity
Poster Opportunity Available

Conferenceseries Destinations


Mail us at

Drop us an email for Program enquiry.
cytopathology@conferenceseries.net
Sponsors / Exhibiting / Advertising.
cytopathology@conferenceseries.com
General Queries.
histopathology@conferenceseries.com

View Proceedings of Previous Conferences

Cytopathology 2016
Cytopathology 2015 Toronto
Pathology 2014
Pathology 2015
Authorization Policy

By registering for the conference you grant permission to Conferenceseries Ltd to photograph, film or record and use your name, likeness, image, voice and comments and to publish, reproduce, exhibit, distribute, broadcast, edit and/or digitize the resulting images and materials in publications, advertising materials, or in any other form worldwide without compensation. Taking of photographs and/or videotaping during any session is prohibited. Contact us for any queries.